United Kingdom · Question · Written question
UIN 16068
Myelodysplastic Syndromes: Drugs
Introduced
15 June 2021
Last action
21 June 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 June 2021
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle regional disparities in drug access for MDS patients in England.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 June 2021
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle regional disparities in drug access for MDS patients in England.
Source: Commons
21 June 2021
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing evidence-based guidance for the National Health Service on whether medicines represent a clinically and cost-effective use of resources. NICE ha...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-06-15/16068
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1336718
- uk · wq-1336718 · source updated 21 June 2021